Table 1 Patients’ demographics and disease characteristics.

From: Defining the Celiac Disease Transcriptome using Clinical Pathology Specimens Reveals Biologic Pathways and Supports Diagnosis

 

Non-Celiac discovery (n = 15)

Celiac discovery (n = 23)

Non-celiac validation (n = 6)

Celiac validation (n = 10)

Age (mean, SD)

8.3(4.3)

8.4(4.4)

7.7(4.8)

7.7(4.9)

Gender Male (n, %)

7 (47%)

11 (48%)

3 (50%)

5 (50%)

Abnormal TTG (n, %)

1 (7%)

23 (100%)

0(0%)

10 (100%)

TTG > 100U/ml (n, %)

—

15 (65%)

—

10 (100%)

Reported abdominal* pain (n, %)

13 (87%)

10 (43%)

4 (66%)

3 (30%)

  1. TTG; tissue trans glutamines.
  2. *From 15 non-Celiac discovery; 13 had endoscopy for abdominal pain, 1 for poor growth, and 1 for anemia. From 6 non-Celiac validation; 4 had endoscopy for abdominal pain, and 2 for poor growth.
Back to article page